If these findings continue to hold with more data, duodenal mucosal resurfacing could represent a novel and much-needed solution to the largest gap in obesity care: post-GLP-1 weight maintenance." REMAIN-1 Midpoint Cohort Study Design The REMAIN-1 Midpoint Cohort (N=45) is a randomized, double-blind, sham-controlled study designed to evaluate Revita in adults with obesity who achieved at least 15% total body weight loss with tirzepatide
Retrieved from Cruickshank, M., Hudson, J., Hernndez, R., et al
In the analyses based on PIONEER 4, oral semaglutide 14 mg was associated with estimated cost savings of GBP 1551 versus liraglutide 1.8 mg over patient lifetimes, driven by the lower acquisition cost of oral semaglutide
Characterization of antibodies against receptor activity-modifying protein 1 (RAMP1): a cautionary tale
Oral tirzepatide is a medication designed to improve glycemic control in adults with type 2 diabetes
Food Editor Brooke Caison liked the Peach Bellini flavor the most, calling it an "overall nice mellow buzz" that "made me feel a little bit giggly." Sign me up